Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 15/20 | 0.49 |
| ▸ | PPARG | P37231 | 13/20 | 0.49 |
| ▸ | PPARD | Q03181 | 2/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PDE8B | O95263 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4925300 | 0.96 | PPARA (0.52) | PPARAPPARGPPARDCNR2KDM4E | |
| SCHEMBL4386267 | 0.96 | PPARA (0.52) | PPARAPPARGPPARDCNR2KDM4E | |
| SCHEMBL4484080 | 0.96 | PPARA (0.52) | PPARAPPARGPPARDCNR2KDM4E | |
| SCHEMBL4377295 | 0.94 | PPARA (0.54) | PPARAPPARGPPARDCNR2KDM4E | |
| SCHEMBL4377298 | 0.94 | PPARA (0.54) | PPARAPPARGPPARDCNR2KDM4E | |
| SCHEMBL4381480 | 0.94 | PPARA (0.54) | PPARAPPARGPPARDCNR2KDM4E | |
| SCHEMBL5180280 | 0.90 | PPARA (0.50) | PPARAPPARGPPARDCNR2KDM4E | |
| SCHEMBL4386752 | 0.90 | PPARA (0.46) | PPARAPPARGPPARDKDM4E | |
| SCHEMBL4375409 | 0.90 | PPARA (0.46) | PPARAPPARGPPARDKDM4E | |
| SCHEMBL4375407 | 0.90 | PPARA (0.46) | PPARAPPARGPPARDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1789402-B1 | 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-1789402-A1 | 2-{-3-2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY };-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | Sanofi-Aventis Deutschland GmbH (DE) | 2007-05-30 | — | — | EP | disclosed |
| WO-2006018118-A1 | 2 - {-3-`2-(PHENYL)-OXAZOL-4-YLMETHOXYMETHYL!-CYCLOHEXYLMETHOXY}-PROPIONIC ACID DERIVATIVES USED AS PPAR LIGANDES (PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS) FOR THE TREATMENT OF HYPERLIPIDAEMIE AND DIABETES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-02-23 | — | — | WO | disclosed |